Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in pediatric cardiac surgery
ChiCTR1900024131Phase 4Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cardiovascular Malformation (CVM) comparing Placebo group with Tranexamic acid group (2 arms). Primary endpoints: Postoperative seizure and Volume of allogeneic red blood cell transfusion after termination of cardiopulmonary bypass. Started Jul 2019; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR1900024131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024131.